Yao, F. and Shi, Z. 2023. MiR-16 is promising to be a therapy target to alleviate atherosclerosis. Diagnostics and Therapeutics. 2, 1 (Jan. 2023), 13–15. DOI:https://doi.org/10.55976/dt.22023116113-15.